Drug Discovery - Medicine.net

Drug Discovery

Sub Categories on Drug Discovery

{{items.name}}

Latest Articles

Smoking status should influence lung cancer staging, new study shows

Smoking status should influence lung cancer staging, new study shows

Updated on: October 02,2025

0

Smoking status should influence lung cancer staging, new study shows

Smoking status should influence lung cancer staging, new study shows

Updated on:October 02,2025

0

Lung cancer rewires immune cells in bone marrow to weaken body's defenses

Lung cancer rewires immune cells in bone marrow to weaken body's defenses

Updated on: October 02,2025

0

Lung cancer rewires immune cells in bone marrow to weaken body's defenses

Lung cancer rewires immune cells in bone marrow to weaken body's defenses

Updated on:October 02,2025

0

New research identifies IFITM3 as key driver of immunotherapy response in small cell lung cancer

New research identifies IFITM3 as key driver of immunotherapy response in small cell lung cancer

Updated on: October 02,2025

0

New research identifies IFITM3 as key driver of immunotherapy response in small cell lung cancer

New research identifies IFITM3 as key driver of immunotherapy response in small cell lung cancer

Updated on:October 02,2025

0

Algorithm uses fluid flow to predict where deadly brain cancer may spread next

Algorithm uses fluid flow to predict where deadly brain cancer may spread next

Updated on: October 02,2025

0

Algorithm uses fluid flow to predict where deadly brain cancer may spread next

Algorithm uses fluid flow to predict where deadly brain cancer may spread next

Updated on:October 02,2025

0

Misconceptions keep some cancer patient populations from benefiting from hormone therapy, survey reveals

Misconceptions keep some cancer patient populations from benefiting from hormone therapy, survey reveals

Updated on: October 02,2025

0

Misconceptions keep some cancer patient populations from benefiting from hormone therapy, survey reveals

Misconceptions keep some cancer patient populations from benefiting from hormone therapy, survey reveals

Updated on:October 02,2025

0

New tool helps identify unreliable research trials

New tool helps identify unreliable research trials

Updated on: October 01,2025

0

New tool helps identify unreliable research trials

New tool helps identify unreliable research trials

Updated on:October 01,2025

0

Inhibiting an astrocytic 'brake' that blocks spinal cord repair could pave path to neuronal regeneration

Inhibiting an astrocytic 'brake' that blocks spinal cord repair could pave path to neuronal regeneration

Updated on: October 02,2025

0

Inhibiting an astrocytic 'brake' that blocks spinal cord repair could pave path to neuronal regeneration

Inhibiting an astrocytic 'brake' that blocks spinal cord repair could pave path to neuronal regeneration

Updated on:October 02,2025

0

Scientists identify novel therapeutic target for ovarian cancer

Scientists identify novel therapeutic target for ovarian cancer

Updated on: October 02,2025

0

Scientists identify novel therapeutic target for ovarian cancer

Scientists identify novel therapeutic target for ovarian cancer

Updated on:October 02,2025

0

Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC, trial shows

Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC, trial shows

Updated on: October 02,2025

0

Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC, trial shows

Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC, trial shows

Updated on:October 02,2025

0

BMS-986504 demonstrates durable responses in MTAP-deleted NSCLC, including EGFR and ALK-positive tumors

BMS-986504 demonstrates durable responses in MTAP-deleted NSCLC, including EGFR and ALK-positive tumors

Updated on: October 02,2025

0

BMS-986504 demonstrates durable responses in MTAP-deleted NSCLC, including EGFR and ALK-positive tumors

BMS-986504 demonstrates durable responses in MTAP-deleted NSCLC, including EGFR and ALK-positive tumors

Updated on:October 02,2025

0

Categories

Anesthesiology & Pain

Cardiology & Vascular surgery

Diabetes & Endocrinology

ENT & HN Surgery

Emergency Medicine & ICU

Epidemiology & Public Health

Family Medicine

Gastroenterology

Hepatobiliary & Pancreas Surgery

Immunology & Rheumatology

Nephrology & Urology

Obstetrics & Gynecology

Orthopedics & Sports medicine